IMI-年轻成人近视的发病与进展
本综述汇总已发表数据,描述18至40岁年轻成人近视的发病与进展,估计成人型近视的频率,评估成人近视进展速率与眼轴延长,识别危险因素,并讨论屈光手术后近视进展及近视管理研究设计。成人型近视在西方人群中常见,占所有近视的三分之一或更多,但在儿童期发病高的东亚较少;临床有意义的近视进展在成年早期持续,20至30岁间可能平均进展1.00屈光度(D)。
要点
- 成人型近视在西方人群占所有近视的三分之一或更多,东亚较少。
- 临床有意义的近视进展在成年早期持续,20至30岁间可能平均1.00 D。
- 儿童期已建立的近视控制方法可作为成人选项,但难以预测其疗效。
核心结论
- 成人型近视常见,在西方人群占所有近视的三分之一或更多,东亚较少。
- 临床有意义的近视进展在成年早期持续,20至30岁间可能平均进展1.00 D。
- 较高水平近视与近视相关眼病和视力损害的绝对风险增高相关,因此该年龄组近视需要持续管理。
研究设计与样本
- 综述:对同行评议文献进行综述,以描述18至40岁年轻成人近视的发病与进展。
主要发现
- 成人型近视在西方人群占所有近视的三分之一或更多,东亚较少。
- 临床有意义的近视进展在成年早期持续,20至30岁间可能平均进展1.00 D。
- 较高水平近视与近视相关眼病和视力损害的绝对风险增高相关。
关键数值与推荐
- 20至30岁间近视进展可能平均1.00 D。
临床怎么用
- 该年龄组近视需要持续管理。
- 儿童期已建立的近视控制方法可作为成人选项,但难以预测其疗效。
局限性
- 成人近视控制研究的可行性受所需持续时间长限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Myopia typically starts and progresses during childhood, but onset and progression can occur during adulthood. The goals of this review are to summarize published data on myopia onset and progression in young adults, aged 18 to 40 years, to characterize myopia in this age group, to assess what is currently known, and to highlight the gaps in the current understanding. Specifically, the peer-reviewed literature was reviewed to: characterize the timeline and age of stabilization of juvenile-onset myopia; estimate the frequency of adult-onset myopia; evaluate the rate of myopia progression in adults, regardless of age of onset, both during the college years and later; describe the rate of axial elongation in myopic adults; identify risk factors for adult onset and progression; report myopia progression and axial elongation in adults who have undergone refractive surgery; and discuss myopia management and research study design. Adult-onset myopia is common, representing a third or more of all myopia in western populations, but less in East Asia, where onset during childhood is high. Clinically meaningful myopia progression continues in early adulthood and may average 1.00 diopters (D) between 20 and 30 years. Higher levels of myopia are associated with greater absolute risk of myopia-related ocular disease and visual impairment, and thus myopia in this age group requires ongoing management. Modalities established for myopia control in children would be options for adults, but it is difficult to predict their efficacy. The feasibility of studies of myopia control in adults is limited by the long duration required.
引用
- Bullimore MA, Lee SS, Schmid KL, et al. IMI-Onset and Progression of Myopia in Young Adults. Invest Ophthalmol Vis Sci. 2023. PMID: 37126362. doi:10.1167/iovs.64.6.2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。